中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
The efficacy and safety of neoadjuvant camrelizumab and chemotherapy for locally advanced thoracic esophageal squamous cell carcinoma

文献类型:期刊论文

作者Xu, Weili; Jiang, Youhua; Wang, Changchun; Wu, Jie; Li, Jianqiang; Hu, Yuqian; Lu, Weishan; Shen, Dijian; Wang, Yinjie; Chen, Qixun
刊名JOURNAL OF CLINICAL ONCOLOGY
出版日期2022-02-01
卷号40
ISSN号0732-183X
DOI10.1200/JCO.2022.40.4_suppl.278
资助项目[JBZX-202006]
WOS研究方向Oncology
语种英语
WOS记录号WOS:000770995900270
出版者LIPPINCOTT WILLIAMS & WILKINS
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/128681]  
专题中国科学院合肥物质科学研究院
作者单位1.Univ Chinese Acad Sci, Canc Hosp, Hangzhou, Peoples R China
2.Univ Chinese Acad Sci, Canc Hosp, Hengzhou, Peoples R China
推荐引用方式
GB/T 7714
Xu, Weili,Jiang, Youhua,Wang, Changchun,et al. The efficacy and safety of neoadjuvant camrelizumab and chemotherapy for locally advanced thoracic esophageal squamous cell carcinoma[J]. JOURNAL OF CLINICAL ONCOLOGY,2022,40.
APA Xu, Weili.,Jiang, Youhua.,Wang, Changchun.,Wu, Jie.,Li, Jianqiang.,...&Chen, Qixun.(2022).The efficacy and safety of neoadjuvant camrelizumab and chemotherapy for locally advanced thoracic esophageal squamous cell carcinoma.JOURNAL OF CLINICAL ONCOLOGY,40.
MLA Xu, Weili,et al."The efficacy and safety of neoadjuvant camrelizumab and chemotherapy for locally advanced thoracic esophageal squamous cell carcinoma".JOURNAL OF CLINICAL ONCOLOGY 40(2022).

入库方式: OAI收割

来源:合肥物质科学研究院

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。